mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.0009 |
mRNA |
XL-184 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
tivozanib |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.001 |
mRNA |
AZ-3146 |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
navitoclax:birinapant (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |
mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.002 |
mRNA |
Sorafenib |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
0.002 |
mRNA |
MLN2480 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.002 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.095 |
0.002 |